01 7Suglat
02 1Sujanu
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 248
2019 Revenue in Millions : 209
Growth (%) : 19
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 253
2020 Revenue in Millions : 247
Growth (%) : 11
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 94
2021 Revenue in Millions : 106
Growth (%) : -10
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 231
2021 Revenue in Millions : 256
Growth (%) : -10
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 139
2017 Revenue in Millions : 106
Growth (%) : 31%
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 82
2015 Revenue in Millions : 57
Growth (%) : 44
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 212
2018 Revenue in Millions : 143
Growth (%) : 48
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 113
2016 Revenue in Millions : 87
Growth (%) : 30
LOOKING FOR A SUPPLIER?
